Erysipelas care episodes (n = 462) in Turku OPAT clinic; structured electronic health record data, January 2018–January 2022
| . | Study period before eCIPs . | Study period after eCIPs . |
|---|---|---|
| (n = 354) . | (n = 108) . | |
| Patient characteristics | ||
| Male, % | 55.6 | 52.8 |
| Age at care episode (years), median (range) | 67 (23–101) | 69 (23–95) |
| Comorbidities | ||
| Hypertension, % | 58.1 | 65.7 |
| Diabetes, % | 31.9 | 38.0 |
| Venous insufficiency, % | 10.7 | 17.6 |
| Arteriosclerosis obliteransa, % | 6.8 | 4.6 |
| Care episode characteristics | ||
| CRPb (mg/l), median (range) | 56 (2–346) | 81 (2–435) |
| Treated with penicillin, % | ||
| Yes | 30.8 | 63.9 |
| No | 69.2 | 36.1 |
| . | Study period before eCIPs . | Study period after eCIPs . |
|---|---|---|
| (n = 354) . | (n = 108) . | |
| Patient characteristics | ||
| Male, % | 55.6 | 52.8 |
| Age at care episode (years), median (range) | 67 (23–101) | 69 (23–95) |
| Comorbidities | ||
| Hypertension, % | 58.1 | 65.7 |
| Diabetes, % | 31.9 | 38.0 |
| Venous insufficiency, % | 10.7 | 17.6 |
| Arteriosclerosis obliteransa, % | 6.8 | 4.6 |
| Care episode characteristics | ||
| CRPb (mg/l), median (range) | 56 (2–346) | 81 (2–435) |
| Treated with penicillin, % | ||
| Yes | 30.8 | 63.9 |
| No | 69.2 | 36.1 |
Erysipelas care episodes (n = 462) in Turku OPAT clinic; structured electronic health record data, January 2018–January 2022
| . | Study period before eCIPs . | Study period after eCIPs . |
|---|---|---|
| (n = 354) . | (n = 108) . | |
| Patient characteristics | ||
| Male, % | 55.6 | 52.8 |
| Age at care episode (years), median (range) | 67 (23–101) | 69 (23–95) |
| Comorbidities | ||
| Hypertension, % | 58.1 | 65.7 |
| Diabetes, % | 31.9 | 38.0 |
| Venous insufficiency, % | 10.7 | 17.6 |
| Arteriosclerosis obliteransa, % | 6.8 | 4.6 |
| Care episode characteristics | ||
| CRPb (mg/l), median (range) | 56 (2–346) | 81 (2–435) |
| Treated with penicillin, % | ||
| Yes | 30.8 | 63.9 |
| No | 69.2 | 36.1 |
| . | Study period before eCIPs . | Study period after eCIPs . |
|---|---|---|
| (n = 354) . | (n = 108) . | |
| Patient characteristics | ||
| Male, % | 55.6 | 52.8 |
| Age at care episode (years), median (range) | 67 (23–101) | 69 (23–95) |
| Comorbidities | ||
| Hypertension, % | 58.1 | 65.7 |
| Diabetes, % | 31.9 | 38.0 |
| Venous insufficiency, % | 10.7 | 17.6 |
| Arteriosclerosis obliteransa, % | 6.8 | 4.6 |
| Care episode characteristics | ||
| CRPb (mg/l), median (range) | 56 (2–346) | 81 (2–435) |
| Treated with penicillin, % | ||
| Yes | 30.8 | 63.9 |
| No | 69.2 | 36.1 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
